SCHEMBL5798539

SCHEMBL5798539

c1cn(-c2nc(NCCc3ccc4c(c3)OCO4)c3c4c(sc3n2)CCCC4)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 9/20 0.49
NOS1 P29475 3/20 0.48
ALDH1A1 P00352 4/20 0.44
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
KDM4E B2RXH2 4/20 0.43
USP2 O75604 2/20 0.43
LMNA P02545 2/20 0.43
ALOX15 P16050 2/20 0.43
HTT P42858 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PTPN12 Q05209 1/20 0.43
PTPN22 Q9Y2R2 1/20 0.43
PRKCI P41743 2/20 0.42
MAPT P10636 3/20 0.42
GLA P06280 2/20 0.42
GAA P10253 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5798039 0.91 PTPN12 (0.47) NOS2NOS1ALDH1A1ADORA2AADORA1
SCHEMBL5801995 0.86 NOS2 (0.46) NOS2NOS1ALDH1A1ADORA2AADORA1
SCHEMBL5777505 0.86 ALDH1A1 (0.44) ALDH1A1KDM4EUSP2LMNAALOX15
SCHEMBL5781513 0.86 ALDH1A1 (0.44) ALDH1A1KDM4EUSP2LMNAALOX15
SCHEMBL5128265 0.84 NOS2 (0.54) NOS2NOS1
SCHEMBL5777963 0.84 KDM4E (0.46) ALDH1A1KDM4EUSP2LMNAALOX15
SCHEMBL5128996 0.83 NOS2 (0.53) NOS2NOS1
SCHEMBL5122969 0.83 NOS2 (0.54) NOS2NOS1
SCHEMBL5779219 0.82 HTT (0.48) ALDH1A1KDM4EUSP2LMNAALOX15
SCHEMBL5780867 0.82 PRKCI (0.66) PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685136-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2006-08-02 EP disclosed
WO-2005047292-A1 USE OF THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2005-05-26 WO disclosed
US-6432950-B1 ANTICANCER AGENTS; KILLING CANCER CELLS CELL PATHWAYS 2002-08-13 US disclosed
US-6133271-A Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 2000-10-17 US disclosed
US-6110920-A TREATMENT OF CARDIOVASCULAR DISORDERS AND IMPOTENCY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-29 US disclosed
EP-0920431-A1 THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 1999-06-09 EP disclosed
WO-1998006722-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1998-02-19 WO disclosed